Latchumanadhas Kalidoss/X
Sep 12, 2026, 13:43
Latchumanadhas Kalidoss: PETROS vs Infusion Thrombolysis in Mitral Valve Thrombosis
Latchumanadhas Kalidoss, Head of Laboratory at Madras Medical Mission, shared a post on X about a recent article he and his colleagues co-authored, published in The American Journal of Cardiology, adding:
“Largest worldwide single centre Obstructive mitral metallic valve thrombosis registry of 128 patients comparing infusion thrombolysis and PETROS procedeure from MMM.”
Title: Outcomes After Percutaneous Transcatheter Release Or Fibrinolysis For Obstructive Mechanical Mitral Valve Thrombosis
Authors: Nandhakumar Vasu, Latchumanadhas Kalidoss, Ashwini, Aashish Chopra, Harini Anandhan, Mullasari S Ajit
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters